-
Signature
-
/s/ Brian E. Anderson, attorney-in-fact for Leah Tate
-
Stock symbol
-
BDC
-
Transactions as of
-
Feb 21, 2025
-
Transactions value $
-
-$25,379
-
Form type
-
4
-
Date filed
-
2/25/2025, 09:51 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
BDC |
Common Stock |
Tax liability |
$0 |
-435 |
-1.87% |
$0.00 |
22.8K |
Feb 21, 2025 |
Direct |
F1 |
transaction |
BDC |
Common Stock |
Tax liability |
$0 |
-241 |
-1.06% |
$0.00 |
22.6K |
Feb 24, 2025 |
Direct |
F2 |
transaction |
BDC |
Common Stock |
Options Exercise |
$23.7K |
+441 |
+1.95% |
$53.79 |
23K |
Feb 24, 2025 |
Direct |
F4 |
transaction |
BDC |
Common Stock |
Disposed to Issuer |
-$30.8K |
-277 |
-1.2% |
$111.09 |
22.7K |
Feb 24, 2025 |
Direct |
F5 |
transaction |
BDC |
Common Stock |
Sale |
-$18.3K |
-164 |
-0.72% |
$111.76 |
22.6K |
Feb 25, 2025 |
Direct |
F6 |
holding |
BDC |
Common Stock |
|
|
|
|
|
3.36K |
Feb 21, 2025 |
By Spouse |
|
holding |
BDC |
Common Stock |
|
|
|
|
|
1.03K |
Feb 21, 2025 |
By 401(k) Plan |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
BDC |
Stock Appreciation Rights |
Options Exercise |
$0 |
-441 |
-100% |
$0.00 |
0 |
Feb 24, 2025 |
Common Stock |
441 |
$53.79 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: